S. Beslija
Clinical Center University of Sarajevo(BA)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix(2011)477 cited
- → Third consensus on medical treatment of metastatic breast cancer(2009)270 cited
- → Second consensus on medical treatment of metastatic breast cancer(2006)97 cited
- → Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial(2013)85 cited
- → Colorectal Cancer Surgical Treatment, our Experience(2019)68 cited
- → Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial(2005)63 cited
- → Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial(2016)58 cited
- → Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement(2016)48 cited
- → A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries(2020)43 cited
- → Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe(2018)33 cited